Price history
Price history loads when this section approaches view.
TradingView data is temporarily unavailable
The rest of this research page remains available.
View this listing on TradingView ↗Company research
CLX
ERP normalization and cost inflation constrained the core business as the GOJO acquisition and Glad venture payment increased leverage and integration demands.
Clorox's April 30 filing showed a stable quarter after substantial ERP-related shipment distortion. Fiscal third-quarter net sales were essentially flat at $1.67 billion and volume was also flat. Household sales rose 3%, but Lifestyle sales fell 9% as volume declined 6% and trade promotion increased. For the first nine months, sales fell 7% and volume declined 6%, largely because the prior fiscal fourth quarter included shipments brought forward ahead of the ERP transition. The comparison therefore remained unusually difficult to interpret as underlying consumption.
Profit quality weakened despite cost savings. Gross margin fell 140 basis points to 43.2%, reflecting higher manufacturing and logistics costs and unfavorable mix. Selling and administrative expense declined 14%, partly because transformation costs and incentive compensation were lower, and diluted EPS increased 3% to $1.54. U.S. retail advertising fell to 11% of sales from 14%, however, so part of the earnings support came from lower brand spending rather than stronger gross economics.
Capital demands increased. Clorox paid $476 million in March to acquire P&G's 20% interest in the Glad venture and completed the GOJO acquisition on April 1. It drew $1.25 billion under a delayed-draw term facility after quarter-end and planned to refinance part of the acquisition borrowing with long-term debt. At March 31, notes and loans payable were about $1.59 billion, current liabilities exceeded current assets by $504 million, and nine-month operating cash flow fell to $282 million from $687 million, principally because of the Glad payment and lower cash earnings. GOJO broadened the health-and-hygiene portfolio, but integration, financing cost and goodwill allocation were unresolved at the cutoff.
The shares fell 6.7% during the quarter, compared with a 14.9% gain for the S&P 500. The largest daily move was a 9.7% decline on May 1, one day after the filing, consistent with concern about margin pressure and the financing burden, although the market move cannot be assigned to one disclosure. At June 30, the main issue was whether normalized ERP comparisons and cost savings could restore gross margin while GOJO was integrated without weakening brand support or balance-sheet flexibility.
| Portfolio Manager | Recent activity | Shares | Value | Portfolio |
|---|---|---|---|---|
| Terry SmithFundsmith LLP | CLXAdded | 271,318 | $25,895,000 | 0.19% |
Long-term company research
Updated 2026-08-03
Clorox manufactures and markets branded consumer and professional products. Health and Wellness includes Clorox, Clorox 2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, CloroxPro, and Clorox Healthcare cleaning and disinfecting products. Household includes Glad bags and wraps, Fresh Step and Scoop Away cat litter, and Kingsford charcoal. Lifestyle includes Hidden Valley dressings and sauces, Brita water filtration, and Burt's Bees personal care. International sells selected brands outside the United States. Smaller or divested activities sit in Corporate and Other.
The company buys chemicals, resin, nonwoven fabric, cardboard, soybean oil, agricultural inputs, packaging, energy, and transport; converts and packages them; builds consumer demand through advertising and innovation; and sells mainly through retailers and distributors. Fiscal 2025 net sales were approximately $7.1 billion. Clorox is therefore a portfolio of category-specific brands sharing procurement, manufacturing, sales, and corporate systems—not one homogeneous cleaning business.
Economic quality differs by category. Bleach and trash bags are frequent, functional purchases with private-label substitutes. Cat litter and water filters can develop habitual repeat demand. Burt's Bees and Hidden Valley rely more on taste, identity, and formulation. Kingsford is seasonal and weather-sensitive. Professional disinfecting depends on institutional standards and distributor access.
The end consumer buys efficacy, safety, familiarity, convenience, scent or taste, package format, and price. Brand matters when it reduces uncertainty—whether a disinfectant works, a bag holds, litter controls odor, or a dressing tastes consistent. Purchase frequency and low unit value can make a trusted default valuable, but shelf price and promotion remain visible. Consumers can switch to private label, another national brand, a reusable product, home-prepared food, or no purchase.
Retailers are Clorox's direct economic customers and possess substantial power over assortment, shelf placement, promotion, inventory, data, and payment terms. Walmart represented 27% of fiscal 2025 sales, up from 25% in 2024; the five largest customers generated nearly half of sales. Retailers can favor their own brands, demand promotional funding, reduce inventory, or delist products. E-commerce improves direct consumer visibility but makes price comparison easier and still depends on platforms and fulfillment networks.
Institutional customers value validated efficacy, regulatory compliance, availability, and training. International consumers face local competitors, lower purchasing power, currency volatility, and different distribution. Clorox can pass through input inflation only if consumer preference and retailer economics support the final shelf price.
Clorox earns profit when sales price and mix exceed raw material, conversion, freight, warehousing, retailer allowances, advertising, selling, administration, depreciation, interest, and tax. Brand-led demand can support a price premium and stable shelf velocity. Manufacturing scale, formulation knowledge, procurement, and a common sales force lower unit cost. Working capital matters because the company buys inputs and carries inventory before retailer collection.
Fiscal 2025 sales were essentially flat, while organic sales and gross margin improved. Diluted earnings per share rose 190%, but the filing attributes much of the comparison to prior-year Argentina divestiture losses and pension settlement expense, plus current-year cost savings and cyberattack insurance recoveries; a loss on the Better Health vitamins, minerals and supplements divestiture and other costs offset part. This is not evidence that underlying profit tripled.
Pricing taken during commodity inflation initially protects dollars while volume may fall. Later input relief expands gross margin, but private label and national competitors can use the same relief to lower prices. Sustainable profit requires holding household penetration and category share after price gaps normalize. A promotional increase can protect volume while transferring economics to consumers and retailers.
Suppliers capture value when resin, chemicals, agricultural inputs, energy, labor, or freight are scarce. Retailers capture trade spending and private-label margin. Joint-venture partners and licensees share certain product economics. Employees, advertising platforms, debt providers, and regulators claim further value before shareholders. The brand owner retains the residual only where consumer pull and operational efficiency exceed these demands.
Clorox competes with multinational consumer-products groups, category specialists, regional brands, and retailer private labels. Substitutes differ by aisle: reusable containers compete with bags, electric or gas grills with charcoal, private-label bleach with Clorox, private-label filters with Brita, and homemade food with Hidden Valley. Competition occurs through price, promotion, performance, innovation, claims, packaging, advertising, and shelf access.
Consumer bargaining power is expressed one basket at a time; switching is easy. Retailer bargaining power is concentrated and immediate. Supplier power rises when specialized materials or single-source inputs are constrained. Advertising platforms and retailers increasingly control consumer data and discovery. Entry is easy for a contract-manufactured niche product but difficult at national scale because distribution, service levels, advertising, regulatory substantiation, and retailer trust require sustained spending.
Capacity cycles are shorter than in heavy industry but still matter. Pandemic disinfecting shortages drew capacity and inventory into cleaning, followed by demand normalization. Commodity inflation led to price increases and cost-saving programs; falling commodities can invite price and promotional competition. Retailer inventory changes amplify reported shipments without changing consumption. Fiscal 2025 orders placed ahead of the U.S. ERP transition benefited sales but were expected to reverse as retailers consumed stock.
Brand investment has its own cycle. Cutting advertising and innovation lifts near-term earnings but weakens future shelf velocity, inviting private label. Excess launches create complexity and write-offs. The rational strategy is sustained demand creation behind a focused portfolio, not maximum SKU count.
Clorox's plausible advantage is a system of trusted category brands, retailer relationships, formulation and claims expertise, scaled manufacturing, and repeat consumer habits. The Clorox name can lower perceived efficacy risk; Hidden Valley owns a recognizable taste; Brita has installed-filter replacement demand; Fresh Step and Burt's Bees combine brand with product experience. Strong shelf velocity gives retailers a reason to allocate space.
This advantage is category-specific and must be demonstrated through stable share, price realization, repeat purchase, and efficient advertising. Recognition alone is insufficient. Bleach chemistry is replicable, trash bags face private label, and retailers control the shelf. Fiscal sales moved from $7.3 billion in 2021 to $7.1 billion in 2022, $7.4 billion in 2023, and about $7.1 billion in both 2024 and 2025. That record supports resilience, not robust organic compounding.
The 2023 cyberattack exposed a further limit: brand demand cannot create revenue when order and supply systems fail. An advantage is durable only if the operating system can deliver product. Persistent share gains after ERP normalization, price premiums with stable volume, and lower cost without weaker service would confirm strength. Recurring distribution loss, growing private-label share, or promotion required to sustain volume would contradict it.
Clorox connects consumer research, formulation, regulatory claims, sourcing, manufacturing, forecasting, retailer replenishment, advertising, and category management. A new product succeeds only when it performs, can be produced at target cost, earns shelf space, and receives repeat purchase. Shared procurement and logistics create scale; category differences require local judgment.
The company is investing an expected $570–$580 million over five years in a new ERP, cloud platform, and related digital technologies. Canada went live first; U.S. implementation began in fiscal 2026. The program may improve planning, digital commerce, and productivity, but transition risk is material after the 2023 cyberattack disrupted order processing. Advance retailer shipments reduce immediate cutover risk while borrowing sales from the next period.
Useful indicators are consumption rather than shipments, market share, price/mix versus volume, gross margin, retailer inventory, service levels, out-of-stocks, innovation repeat rates, commodity savings, and ERP errors. Employee count fell from roughly 9,000 in 2021–2022 to 7,600 in 2025. That can evidence a streamlined model only if innovation, control, and customer service remain intact.
Clorox finances inventories, factories, technology, dividends, and debt service from recurring consumer cash flow and credit-market access. Demand for household staples is comparatively defensive, but cash earnings can compress when commodities rise faster than pricing or a system failure prevents shipment. Senior debt, commercial paper capacity, leases, pension obligations, and retailer working-capital swings all matter alongside reported borrowings.
The cyberattack is the most informative stress in the filing set. It materially disrupted operations and financial results, with recovery extending into fiscal 2024 and insurance recoveries benefiting fiscal 2025. Insurance reduced the financial loss but did not prevent operational damage. The ERP conversion creates another concentrated execution period.
Resilience requires liquidity sufficient for elevated inventory, duplicate systems, retailer deductions, and remediation while continuing advertising. Brand spending and maintenance cannot be cut indefinitely without harming the franchise. Acquired goodwill and trademarks may also be impaired when a category underperforms; they do not provide debt-service liquidity. The balance sheet should be judged under simultaneous volume weakness, commodity inflation, and technology disruption rather than an average year.
Clorox allocates capital among brand support, innovation, productivity, ERP, factories, dividends, repurchases, acquisitions, and debt. The digital transformation is unusually large relative to ordinary capital needs. It creates value only if savings, service, and decision quality exceed implementation and disruption costs. Spending that merely replaces an obsolete system is necessary maintenance, not incremental growth.
Portfolio actions have removed Argentina and Better Health VMS, reducing complexity but producing accounting losses. Divestitures can improve future focus even when sale proceeds fall below carrying value; the loss also reveals that prior capital did not earn the expected outcome. Acquisitions deserve skepticism when they add goodwill, unfamiliar channels, or weak brands.
The dividend provides cash to shareholders but should remain subordinate to operating resilience and prudent leverage. Repurchases create per-share value only below intrinsic value and after required brand and system investment. Management should be judged on per-share cash after normalized commodity, advertising, restructuring, and technology costs—not adjusted earnings that exclude recurring transformation or portfolio consequences.
Products are governed by consumer safety, environmental, labeling, advertising, chemical, food, drug, cosmetic, occupational, privacy, and competition rules. Disinfectant claims require registration and substantiation; food and personal-care ingredients face safety and labeling standards. Product contamination, ineffective claims, recalls, or packaging defects can lead to refunds, litigation, retailer action, and lasting brand damage.
Environmental exposure includes chemicals, waste, plastic packaging, emissions, and remediation. Tariffs and trade rules affect imported inputs and international operations. Privacy and cybersecurity obligations cover consumer promotions, loyalty data, employees, retailers, and vendors. International operations add currency controls, anti-bribery, labor, tax, and price regulation.
Regulation can protect established products by raising testing and compliance costs, but it can also limit ingredients, packaging, claims, or pricing. The economic consequence of a legal failure is often lost distribution and trust, not merely a fine.
Clorox creates value by combining trusted, frequently purchased brands with scaled production and retail distribution. Consumer familiarity can support velocity and modest pricing, while procurement and shared systems lower cost. The company retains value only after powerful retailers, commodity suppliers, advertising platforms, and competitors take their share.
The evidence shows resilience but also limited growth and meaningful execution risk. Fiscal 2025 profit comparisons contain divestiture, pension, cyber-insurance, and ERP inventory effects; they are not normalized economics. Walmart concentration, private-label substitution, flat multi-year sales, and the prior cyber disruption contradict a simplistic brand-moat account.
The thesis would be invalidated by sustained unit and market-share losses after pricing normalizes; retailers widening private-label placement or demanding structurally higher trade spending; ERP disruption that again impairs service; technology spending failing to create measurable savings; commodity inflation that cannot be passed through; or dividends and repurchases leaving inadequate resilience. At the cutoff, Clorox remains a defensible collection of category franchises, but durable shareholder outcomes depend on execution and retailer-adjusted economics more than brand recognition alone.
Business quality does not by itself establish investment attractiveness; valuation depends on the price paid and the expectations embedded in it.
Insider activity
Open-market purchases and sales only.